B. Escudier
- Topics
- Renal cell carcinoma treatment (23 papers)Cancer Genomics and Diagnostics (11 papers)Economic and Financial Impacts of Cancer (7 papers)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
B. Escudier
38 papers receiving 316 citations
Peers
Comparison fields: 5 of 50
- Pulmonary and Respiratory Medicine 221
- Molecular Biology 189
- Cancer Research 120
- Oncology 94
- Surgery 48
Countries citing papers authored by B. Escudier
This map shows the geographic impact of B. Escudier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Escudier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Escudier more than expected).
Fields of papers citing papers by B. Escudier
This network shows the impact of papers produced by B. Escudier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Escudier. The network helps show where B. Escudier may publish in the future.
Co-authorship network of co-authors of B. Escudier
This figure shows the co-authorship network connecting the top 25 collaborators of B. Escudier. A scholar is included among the top collaborators of B. Escudier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Escudier. B. Escudier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Genetic Markers in Relation to Bevacizumab-induced Hypertension | 1 |
| 3 | 12 | |
| 4 | 40 | |
| 5 | 1 | |
| 6 | 38 | |
| 7 | 4 | |
| 8 | 8 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 0 | |
| 12 | 2 | |
| 13 | 4 | |
| 14 | 7 | |
| 15 | 2 | |
| 16 | [A multivariate prospective study of prognostic factors in 200 operated epidermoid cancers of the esophagus. Definition of patients for whom surgical resection was of benefit]. | 4 |
| 17 | Esophageal squamous cell carcinoma: the specific limited place of surgery defined by a prospective multivariate study of prognostic factors after surgical approach. | 5 |
| 18 | 7 | |
| 19 | 2 | |
| 20 | [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine]. | 2 |
About B. Escudier
B. Escudier is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 41 papers that have together received 327 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (23 papers), Cancer Genomics and Diagnostics (11 papers) and Economic and Financial Impacts of Cancer (7 papers). The work is most often cited by research in Cancer Research (120 citations), Pulmonary and Respiratory Medicine (221 citations) and Oncology (94 citations). B. Escudier has collaborated with scholars based in France, United States and Canada. Frequent co-authors include J. Vinke, J Maral, Sylvie Négrier, Alain Ravaud, T Philip, Sylvie Négrier, Andrea Harzstark, M. Shi, Eric Angevin and Jürgen E. Gschwend. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.